The inner ear is the organ responsible for hearing and balance. Inner ear dysfunction can be the result of infection, trauma, ototoxic drugs, genetic mutation or predisposition. Often, like for Ménière disease, the cause is unknown. Due to the complex access to the inner ear as a fluid-filled cavity within the temporal bone of the skull, effective diagnosis of inner ear pathologies and targeted drug delivery pose significant challenges. Samples of inner ear fluids can only be collected during surgery because the available procedures damage the tiny and fragile structures of the inner ear. Concerning drug administration, the final dose, kinetics, and targets cannot be controlled. Overcoming these limitations is crucial for successful inner ear precision medicine. Recently, notable advancements in microneedle technologies offer the potential for safe sampling of inner ear fluids and local treatment. Ultrasharp microneedles can reach the inner ear fluids with minimal damage to the organ, collect μl amounts of perilymph, and deliver therapeutic agents in loco. This review highlights the potential of ultrasharp microneedles, combined with nano vectors and gene therapy, to effectively treat inner ear diseases of different etiology on an individual basis. Though further research is necessary to translate these innovative approaches into clinical practice, these technologies may represent a true breakthrough in the clinical approach to inner ear diseases, ushering in a new era of personalized medicine.
Oxytocin (OT) is a neuropeptide that modulates social-related behavior and cognition in the central nervous system of mammals. In the CA1 area of the hippocampus, the indirect effects of the OT on the pyramidal neurons and their role in information processing have been elucidated. However, limited data are available concerning the direct modulation exerted by OT on the CA1 interneurons (INs) expressing the oxytocin receptor (OTR). Here, we demonstrated that TGOT (Thr4,Gly7-oxytocin), a selective OTR agonist, affects not only the membrane potential and the firing frequency but also the neuronal excitability and the shape of the action potentials (APs) of these INs in mice. Furthermore, we constructed linear mixed-effects models (LMMs) to unravel the dependencies between the AP parameters and the firing frequency, also considering how TGOT can interact with them to strengthen or weaken these influences. Our analyses indicate that OT regulates the functionality of the CA1 GABAergic INs through different and independent mechanisms. Specifically, the increase in neuronal firing rate can be attributed to the depolarizing effect on the membrane potential and the related enhancement in cellular excitability by the peptide. In contrast, the significant changes in the AP shape are directly linked to oxytocinergic modulation. Importantly, these alterations in AP shape are not associated with the TGOT-induced increase in neuronal firing rate, being themselves critical for signal processing.
Pimozide is a conventional antipsychotic drug largely used in the therapy for schizophrenia and Tourette’s syndrome. Pimozide is assumed to inhibit synaptic transmission at the CNS by acting as a dopaminergic D2 receptor antagonist. Moreover, pimozide has been shown to block voltage-gated Ca2+ and K+ channels in different cells. Despite its widespread clinical use, pimozide can cause several adverse effects, including extrapyramidal symptoms and cardiac arrhythmias. Dizziness and loss of balance are among the most common side effects of pimozide. By using the patch-clamp whole-cell technique, we investigated the effect of pimozide [3 μM] on K+ channels expressed by chicken embryo vestibular type-II hair cells. We found that pimozide slightly blocks a transient outward rectifying A-type K+ current but substantially increases a delayed outward rectifying K+ current. The net result was a significant hyperpolarization of type-II hair cells at rest and a strong reduction of their response to depolarizing stimuli. Our findings are consistent with an inhibitory effect of pimozide on the afferent synaptic transmission by type-II hair cells. Moreover, they provide an additional key to understanding the beneficial/collateral pharmacological effects of pimozide. The finding that pimozide can act as a K+ channel opener provides a new perspective for the use of this drug.
Head movements are detected and signalled to primary sensory neurons by vestibular types I and II hair cells. Signal transmission involves glutamate exocytosis from hair cells, which is triggered by Ca2+ inflow through voltage‐gated CaV1.3 Ca2+ channels. In a previous study on mice, we reported a Ca2+‐dependent exocytosis in both hair cell types, measured as a sustained change in cell membrane capacitance (ΔCm) following cell depolarization, which was significantly smaller in type I than in type II hair cells. By contrast, only type I hair cells showed a large transient ΔCm, which was still present in CaV1.3−/− mouse type I hair cells. Here we investigated the nature of this transient ΔCm. We found that it was unaffected by 10 mm intracellular EGTA, which blocked most of the sustained exocytosis in these cells, demonstrating its insensitivity to intracellular Ca2+. Moreover the amplitude of the transient ΔCm correlated with the degree of activation of the low‐voltage activated outward rectifying K+ conductance, GK,L, expressed by type I, but not type II hair cells. Finally the sign and kinetics of the transient ΔCm changed based on voltage steps activating or deactivating GK,L. These findings are consistent with the transient ΔCm arising from the mobilization of charges during the gating of K,L channels, while excluding fast transient neurotransmitter exocytosis. Its large amplitude can be explained by the high resistance of the calyceal synaptic cleft since it was significantly reduced in Caspr−/− mice, which show a significantly larger synaptic cleft compared to wild type mice. image Key points: Vestibular type I and type II hair cells signal head movement to the central nervous system. Signal transmission from both hair cell types relies on Ca2+‐dependent glutamate exocytosis, measured here as a sustained change in cell membrane capacitance (ΔCm). Type I hair cells exhibit also a large transient ΔCm, whose nature has not been elucidated. In this study we found that the transient ΔCm does not involve exocytosis, but it is generated by the gating of the low‐voltage activated outward rectifying K+ conductance, specifically expressed in type I hair cells. Transient ΔCm analysis (also carried out in mice lacking the core protein of the septate‐like junction) conclusively demonstrates that type I hair cells, like type II ones, do not elicit a transient release of neurotransmitter. Knowledge of the basic mechanisms of vestibular signalling is crucial in the study of pharmacological treatment for vestibular disorders and in the drug side effects targeted there.
Riluzole (Rilutek), a derivative of benzothiazole, acts as a neuroprotective agent by inhibiting voltage‐dependent sodium (Na + ) and delaying rectifier potassium (K + ) currents. By doing so, it helps reduce excitotoxicity, a key pathogenetic mechanism in various neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS). Although riluzole is a clinically approved treatment for ALS, it is not fully effective, particularly in advanced stages of the disease. In this study, we functionally characterized a newly synthetized riluzole‐based compound, VA945, with potentially enhanced neuroprotective effects. By means of SH‐SY5Y human neuroblastoma cells differentiated into neurons, we assessed using whole‐cell patch‐clamp techniques the effects of VA945 on voltage‐dependent Na + and K + currents at extracellular concentrations of 5, 50, and 100 μM. The compound reduced maximal activation and inactivation of Na + conductance, as well as maximal activation of K + conductance, across all tested concentrations. We also observed shifts of the activation and inactivation curves to more hyperpolarized potentials along with changes in the slope factor ( k ), indicating an altered voltage sensitivity of voltage‐dependent K + and Na + channels. While the activation kinetics of both channels remained unaffected, and the inactivation kinetics of Na + were unchanged, we noted a slowdown in the deactivation kinetics of the K + channels. Altogether, these findings suggest that VA945 exerts multi‐target pharmacological effects on neuronal voltage‐dependent ion currents critically involved in excitotoxicity and neurodegeneration, across a wide range of concentrations. This warrants further ex vivo and/or in vivo studies to explore its potential as a neuroprotective agent. image